Nevertheless, small molecule inhibition of two members of the CPC (AURKB and survivin) independently inhibit VP-MCC xenograft growth in vivo, demonstrating the significance of the CPC complex to VP-MCC viability. This evidence concerns the gene BIRC5 and Merkel cell skin cancer.